Case; Brenda

Patent Applications and Registrations

Patent applications and USPTO patent grants for Case; Brenda.The latest application filed is for "6-membered heterocyclic compounds useful for selective inhibition of the coagulation cascade".

Company Profile

0.6.12

Case; Brenda - St. Louis MO

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Substituted polycyclic aryl and heteroarpyl pyrazinones useful for selective inhibition of the coagulation cascade Grant 7,119,094 - South , et al. October 10, 2	2006-10-10
Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade Grant 7,105,559 - South , et al. September 12, 2	2006-09-12
6-Membered heterocyclic compounds useful for selective inhibition of the coagulation cascade App 20050267123 - South, Michael S. ; et al.	2005-12-01
6-membered heterocyclic compounds useful for selective inhibition of the coagulation cascade Grant 6,969,715 - South , et al. November 29, 2	2005-11-29
Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade App 20050239860 - South, Michael S. ; et al.	2005-10-27
Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade App 20050153965 - South, Michael S. ; et al.	2005-07-14
Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade Grant 6,828,338 - South , et al. December 7, 2	2004-12-07
6-Membered unsaturated heterocyclic compounds useful for selective inhibition of the coagulation cascade App 20040106626 - South, Michael S. ; et al.	2004-06-03
Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade App 20040102448 - South, Michael S. ; et al.	2004-05-27
Prodrugs of substituted polycyclic compounds useful for selective inhibition of the coagulation cascade App 20040082585 - South, Michael S. ; et al.	2004-04-29
Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade App 20040068113 - South, Michael S. ; et al.	2004-04-08
Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade App 20040002494 - South, Michael S. ; et al.	2004-01-01
Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade Grant 6,664,255 - South , et al. December 16, 2	2003-12-16
Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade Grant 6,624,180 - South , et al. September 23, 2	2003-09-23
Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade App 20030162776 - South, Michael S. ; et al.	2003-08-28
Substituted Polycyclic Aryl And Heteroaryl Pyridines Useful For Selective Inhibition Of The Coagulation Cascade App 20030139401 - South, Michael S. ; et al.	2003-07-24
6-Membered heterocyclic compounds useful for selective inhibition of the coagulation cascade App 20030139405 - S. South, Michael ; et al.	2003-07-24
Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade App 20020198199 - South, Michael J. ; et al.	2002-12-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.